Jerry Cheng

Jerry Cheng, M.D.

  • Staff Physician, Department of Pediatrics

Jerry Cheng, M.D.

  • 2014-Present, Research Staff, Department of Pediatrics, City of Hope, Duarte, CA
  • 2017, Assistant Clinical Professor, David Geffen School of Medicine at UCLA, Los Angeles, CA
  • 2016, Advisory Council – Chair for 2016, Kaiser Permanente National Transplant Services
  • 2013-Present, Bone Marrow Transplant Section, Chair, Kaiser Permanente National Transplant Services
  • 2009-Present, Co-principal Investigator for Children’s Oncology Group, Kaiser Permanente Southern California Medical Group
  • 2009-Present, Pediatric Bone Marrow Transplant Director, Kaiser Permanente Southern California Medical Group
  • 2007-Present, Staff Pediatric Hematologist-Oncologist, Kaiser Permanente Los Angeles Medical Center
  • 2007-Present, Clinical Instructor in Pediatrics, David Geffen School of Medicine at UCLA



1500 East Duarte Road, Duarte, CA, 91010

Get Directions

Phone :  626-256-4673


  • 1996, B.S. Molecular and Cell Biology, honors, magna cum laude, University of California, Berkeley, CA
  • 2001, M.D., University of California at San Diego, School of Medicine, San Diego, CA


  • 2004-2007, Pediatric Hematology-Oncology, Mattel Children's Hospital at UCLA, Los Angeles, CA


  • 2002-2004, Pediatrics, Mattel Children's Hospital at UCLA, Los Angeles, CA


  • 2001-2002, Pediatrics, Mattel Children's Hospital at UCLA, Los Angeles, CA
  • Breckler, J., Cheng, J., Au, K., and Burnside, B.  “Novel Myosin VI Isoforms Are Abundantly Expressed in Retina.” Experimental Eye Research Jan. 2000 (70): 121-134.
  • Mora-Garcia, P., Cheng, J., Crans-Vargas, HN., Countouriotis, A., and Sakamoto, K. Transcriptional Regulators and Myelopoiesis: The Role of SRF and CREB as Targets of Cytokine Signaling. Stem Cells. 2003; 21:123-130.
  • Cheng, J. Tick Paralysis Case Report. Peds in Review 8/03.
  • Kanegaye, J., Cheng, J., McCaslin, I., Trocinski, D., and Silva, T. Improved Documentation of Wound Care With a Structured Encounter Form in the Pediatric Emergency Department. Ambulatory Pediatrics July-August 2005; 5(4): 253- 257.
  • Cheng, J., Moore, T.B., and Sakamoto, K., RNA Interference and Human Disease. Molecular Genetics and Metabolism, 2003 Sep-Oct;80(1-2): 121-8.
  • Shankar, D.B., Cheng, J., Wang, J., Pan, R., Countouriotis, A., Federman, N., Gill, A., Rao, N.P., Moore, T., and Sakamoto, K.M. “The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.” Cancer Cell, 7:351-362, 2005.
  • Cheng, J., Esparza, S., Sakamoto, K., and Moore, T.B. Severe Lactic Acidosis in a Fourteen Year-old Female with Metastatic  Undifferentiated Carcinoma of Unknown Primary. Journal of Pediatric Hematology-Oncology, October 2004.
  • Cheng, J. and Sakamoto, K. “The Emerging Role of RNA Interference in the Design of Novel Therapeutics in Oncology.” October, Cell Cycle, 2004.
  • Cheng, J., and Sakamoto, K.M. “Management of Pediatric Acute Myeloid Leukemia” Medscape General Medicine: Topics in Pediatric Leukemia (
  • Shankar, D., Cheng, J.C., and Sakamoto, K.M. The Role of Cyclic AMP Response Element Binding Protein in Human Leukemias. Invited Review, Cancer, Sep 29, 2005.
  • Cheng, J.C., Sakamoto, K.M., Horwitz, E.M., Karsten, S.L., Shoemaker, L., Kornblum, H.I., and Malik, P.  “A Meeting Report: “New Technologies in Stem Cell Research.” Stem Cells  Jan 25, 2007.
  • Cheng, J.C., Esparza, S.E., and Sakamoto, K.M. “Potential role of CREB as a prognostic marker in acute myeloid leukemia.” Future Oncology, Aug. 2007;3(4):475-80.
  • Cheng, J.C., Kinjo, K., Wu, Winston., et al., “CREB is a critical regulator of normal hematopoiesis and leukemogenesis.” Blood, Feb. 1 2008; 111(3):1182-92.
  • Pellegrini, M., Cheng, J.C., Sakamoto, K.M., et al., “Expression Profile of CREB knockdown in Myeloid Leukemia Cells.” BMC Cancer,  2008, 8:264.
  • Solis O.E., Mehta R.I., Lai A, Mehta R.I., Farchoukh L.O., Green R.M., Cheng J.C., Natarajan S, Vinters H.V., Cloughesy T, and Yong W.H. “Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases.” J NeuroOncology, Sep 25, 2010.
  • Tidwell,T., Weschler, J., Ramesh, C., Trump, L., Salipante, S., Cheng, J.C., et al. Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms. Blood. November 1, 2013.
  • Epstein, Joel B, Raber-Durlacher, JE, Huysmans, MC, Schoordijk, M., Cheng, J.C., Bensadoun RJ, and Arany, P. Photobiomodulation therapy alleviates tissue fibroses associated with graft-versus-host disease: literature review and case reports. Photomedicine and Laser Surgery. Submitted March 2017.
  • 2007-Present, American Society of Pediatric Hematology-Oncology
  • 2005-Present, American Society of Blood and Marrow Transplantation
  • 2005-Present, American Board of Pediatrics
  • 2004-Present, American Society of Hematology
Back To Top